135 related articles for article (PubMed ID: 16690295)
1. [Chronic autoimmune hemolytic anemia: toward new treatments?].
Bader-Meunier B; Leverger G
Arch Pediatr; 2006 Jun; 13(6):517-9. PubMed ID: 16690295
[No Abstract] [Full Text] [Related]
2. [New treatments for systemic diseases].
Bader-Meunier B; Willems M
Arch Pediatr; 2006 Jun; 13(6):596-8. PubMed ID: 16690273
[No Abstract] [Full Text] [Related]
3. B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia.
Zaja F; Iacona I; Masolini P; Russo D; Sperotto A; Prosdocimo S; Patriarca F; de Vita S; Regazzi M; Baccarani M; Fanin R
Haematologica; 2002 Feb; 87(2):189-95. PubMed ID: 11836170
[TBL] [Abstract][Full Text] [Related]
4. Anti-CD20 monoclonal antibody therapy for autoimmune hemolytic anemia following T cell-depleted, haplo-identical stem cell transplantation.
Ship A; May W; Lucas K
Bone Marrow Transplant; 2002 Feb; 29(4):365-6. PubMed ID: 11896436
[No Abstract] [Full Text] [Related]
5. [Anti-CD20 monoclonal antibody for the treatment of refractory autoimmune hemolytic anemia].
Wang L; Xu W; Li JY; Xie XY; Sheng RL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):425-8. PubMed ID: 17493362
[TBL] [Abstract][Full Text] [Related]
6. Alemtuzumab for giant cell hepatitis with autoimmune hemolytic anemia.
Rovelli A; Corti P; Beretta C; Bovo G; Conter V; Mieli-Vergani G
J Pediatr Gastroenterol Nutr; 2007 Nov; 45(5):596-9. PubMed ID: 18030239
[No Abstract] [Full Text] [Related]
7. Mycophenolate mofetil for severe autoimmune haemolytic anemia.
Zimmer-Molsberger B; Knauf W; Thiel E
Lancet; 1997 Oct; 350(9083):1003-4. PubMed ID: 9329520
[No Abstract] [Full Text] [Related]
8. [Autoimmune hemolytic anemia].
Karasawa M
Nihon Rinsho; 2008 Mar; 66(3):520-3. PubMed ID: 18326320
[TBL] [Abstract][Full Text] [Related]
9. Childhood refractory autoimmune haemolytic anaemia: is there a role for anti-CD20 therapy (rituximab)?
McMahon C; Babu L; Hodgson A; Hayat A; Connell NO; Smith OP
Br J Haematol; 2002 May; 117(2):480-3. PubMed ID: 11972537
[No Abstract] [Full Text] [Related]
10. Successful induction and maintenance of long-term remission in a child with chronic relapsing autoimmune hemolytic anemia using rituximab.
Gottardo NG; Baker DL; Willis FR
Pediatr Hematol Oncol; 2003; 20(7):557-61. PubMed ID: 12959862
[TBL] [Abstract][Full Text] [Related]
11. [Autoimmune haemolytic anemia: diagnosis strategy and new treatments].
Rigal D; Meyer F
Transfus Clin Biol; 2011 Apr; 18(2):277-85. PubMed ID: 21474357
[TBL] [Abstract][Full Text] [Related]
12. Treatment of stiff person syndrome with rituximab.
Baker MR; Das M; Isaacs J; Fawcett PR; Bates D
J Neurol Neurosurg Psychiatry; 2005 Jul; 76(7):999-1001. PubMed ID: 15965211
[TBL] [Abstract][Full Text] [Related]
13. Treatment of refractory autoimmune haemolytic anaemia with anti-CD20 (rituximab).
Ahrens N; Kingreen D; Seltsam A; Salama A
Br J Haematol; 2001 Jul; 114(1):244-5. PubMed ID: 11472378
[No Abstract] [Full Text] [Related]
14. Rituximab: a very efficient therapy in cold agglutinins and refractory autoimmune haemolytic anaemia associated with CD20-positive, low-grade non-Hodgkin's lymphoma.
Bauduer F
Br J Haematol; 2001 Mar; 112(4):1085-6. PubMed ID: 11324638
[No Abstract] [Full Text] [Related]
15. Anti B cell targeted immunotherapy for treatment of refractory autoimmune haemolytic anaemia in a young infant.
Ng PC; Lee KK; Lo AF; Li CK; Fok TF
Arch Dis Child; 2003 Apr; 88(4):337-9. PubMed ID: 12651764
[TBL] [Abstract][Full Text] [Related]
16. Anti-CD20 monoclonal antibody for the treatment of refractory autoimmune haemolytic anaemia associated with idiopathic membranous nephropathy.
Rossi P; Demoux AL; Granel B; Bagnères D; Bonin-Guillaume S; Frances Y
Rheumatology (Oxford); 2005 Mar; 44(3):403-5. PubMed ID: 15637040
[No Abstract] [Full Text] [Related]
17. Use of mycophenolate mofetil for chronic, refractory immune cytopenias in children with autoimmune lymphoproliferative syndrome.
Rao VK; Dugan F; Dale JK; Davis J; Tretler J; Hurley JK; Fleisher T; Puck J; Straus SE
Br J Haematol; 2005 May; 129(4):534-8. PubMed ID: 15877736
[TBL] [Abstract][Full Text] [Related]
18. Allogeneic stem cell transplantation for Evans syndrome.
Oyama Y; Papadopoulos EB; Miranda M; Traynor AE; Burt RK
Bone Marrow Transplant; 2001 Nov; 28(9):903-5. PubMed ID: 11781654
[TBL] [Abstract][Full Text] [Related]
19. Favourable response to therapy with the anti-CD20 monoclonal antibody rituximab in primary chronic cold agglutinin disease.
Berentsen S; Tjønnfjord GE; Brudevold R; Gjertsen BT; Langholm R; Løkkevik E; Sørbø JH; Ulvestad E
Br J Haematol; 2001 Oct; 115(1):79-83. PubMed ID: 11722415
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment with rituximab and mycophenolate mofetil of refractory autoimmune hemolytic anemia post-hematopoietic stem cell transplant for dyskeratosis congenita due to TINF2 mutation.
O'Connell N; Goodyer M; Gleeson M; Storey L; Williams M; Cotter M; O'Marcaigh A; Smith O
Pediatr Transplant; 2014 Feb; 18(1):E22-4. PubMed ID: 24168326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]